Chronic Cutaneous Ulcers Epidemiology Forecast 2025-2034

Chronic cutaneous ulcers, commonly affecting 1% of middle-aged and elderly individuals, result from conditions like venous insufficiency, arterial insufficiency, or diabetes. Risk factors include ageing, obesity, smoking, and multiple pregnancies, with venous insufficiency being the leading cause. A 25-year study found that 0.47% of CLUs developed skin cancer, mostly basal and squamous cell carcinomas, in elderly patients.

Chronic Cutaneous Ulcers Epidemiology Forecast Report Coverage

The “Chronic Cutaneous Ulcers Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of chronic cutaneous ulcers. It projects the future incidence and prevalence rates of chronic cutaneous ulcers across various populations. The study covers age and type as major determinants of the chronic cutaneous ulcers-affected population. The report highlights patterns in the prevalence of chronic cutaneous ulcers over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of chronic cutaneous ulcers in the 8 major markets.

Regions Covered

• The United States
• Germany
• France
• Italy
• Spain
• The United Kingdom
• Japan
• India

Chronic Cutaneous Ulcers: Disease Overview

Chronic cutaneous ulcers are long-lasting wounds that fail to heal properly, often persisting for weeks or months. They commonly affect about 1% of middle-aged and elderly individuals, typically arising from underlying conditions like venous insufficiency, arterial insufficiency, or diabetes. Venous insufficiency is the leading cause, accounting for 45-80% of cases, with contributing factors such as ageing, obesity, smoking, and multiple pregnancies. Chronic ulcers are characterised by persistent inflammation, abnormal granulation tissue, and slow healing. Complications include recurrent infections and, in some cases, malignant transformation into skin cancers, such as basal or squamous cell carcinoma, particularly in older populations.

Chronic Cutaneous Ulcers: Treatment Overview

Treatment of chronic cutaneous ulcers focuses on addressing underlying causes, promoting wound healing, and preventing complications. For venous ulcers, compression therapy improves blood flow, while diabetic ulcers benefit from optimised blood sugar control and offloading pressure. Wound care includes debridement to remove dead tissue, antimicrobial dressings to prevent infection, and advanced options like negative pressure wound therapy or skin grafts for severe cases.

Medications such as antibiotics treat infections, and vascular procedures improve circulation in arterial ulcers. Lifestyle modifications, including weight management, smoking cessation, and managing comorbidities like hypertension and diabetes, support recovery. Multidisciplinary care ensures optimal outcomes. In a study of 25 patients with chronic pedal ulcers, the mean ulcer duration was 7.84 years, with an average healing time of 5.97 months. Among these, 76% had atypical ulcers, 16% had venous ulcers, and 8% had diabetic neuropathy ulcers.

Epidemiology

The chronic cutaneous ulcers epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for chronic cutaneous ulcers by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for chronic cutaneous ulcers and their trends. The data is broken down into specific categories, such as the total diagnosed cases across different age groups and patient pools.

• Chronic leg ulceration affects approximately 1% of the middle-aged and elderly population, most often following minor injuries associated with venous insufficiency (45-80%), chronic arterial insufficiency (5-20%), diabetes (15-25%), or hypertension.
• Venous insufficiency is the most common underlying cause, with rates as high as 50% in certain populations, affecting all races and both sexes equally. Prevalence increases with age, obesity, family history of varicose veins, and multiple pregnancies.
• A United States study identified higher rates of venous insufficiency among ethnic whites compared to Hispanics, African Americans, and Asians.
• A retrospective cohort study in Olmsted County revealed an incidence rate of chronic leg ulcers at 470 per 100,000 patients, predominantly affecting elderly non-Hispanic white females.

Country-wise Chronic Cutaneous Ulcers Epidemiology

The chronic cutaneous ulcers epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Chronic cutaneous ulcers are increasingly prevalent due to an ageing population and the rising incidence of conditions like diabetes. In the United Kingdom, it is estimated that between 70,000 and 190,000 individuals suffer from venous leg ulcers, with approximately 400,000 people developing pressure sores annually. Additionally, 64,000 individuals experience foot ulceration, leading to around 2,600 amputations each year. These statistics highlight the growing burden of chronic wounds and the need for effective treatments and preventative measures.

Scope of the Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of chronic cutaneous ulcers based on several factors.
• Chronic Cutaneous Ulcers Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The report helps to identify the patient population, and the unmet needs of Manisha Gautam are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

• What are the key findings of chronic cutaneous ulcers epidemiology in the 8 major markets?
• What will be the total number of patients with chronic cutaneous ulcers across the 8 major markets during the forecast period?
• What was the country-wise prevalence of chronic cutaneous ulcers in the 8 major markets in the historical period?
• Which country will have the highest number of chronic cutaneous ulcers patients during the forecast period of 2025-2034?
• Which key factors would influence the shift in the patient population of chronic cutaneous ulcers during the forecast period of 2025-2034?
• What are the currently available treatments for chronic cutaneous ulcers?
• What are the disease risks, signs, symptoms, and unmet needs of chronic cutaneous ulcers?

This product will be delivered within 3-5 business days.